Adar Poonawalla, WHO warn of delays as US prioritises Pfizer

Adar Poonawalla, the chief executive officer of the Serum Institute of India —which is licensed to produce hundreds of millions of Covid-19 vaccines from AstraZeneca and Novavax — told a World Bank panel on Thursday that a US law blocking the export of certain key items, including bags and filters, will likely cause serious bottlenecks.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ro1e9J
via IFTTT